These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
5. Effect of folic or folinic acid supplementation on methotrexate-associated safety and efficacy in inflammatory disease: a systematic review. Prey S; Paul C Br J Dermatol; 2009 Mar; 160(3):622-8. PubMed ID: 18945303 [TBL] [Abstract][Full Text] [Related]
6. [Methotrexate]. Rau R Z Rheumatol; 2016 Aug; 75(6):599-603. PubMed ID: 27365027 [No Abstract] [Full Text] [Related]
8. Methotrexate in psoriasis: do we need to give a test dose? Carretero-Hernández G Actas Dermosifiliogr; 2012 Jan; 103(1):1-4. PubMed ID: 22440152 [No Abstract] [Full Text] [Related]
9. Nonsteroidal anti-inflammatory drugs. Wolf RE Arch Intern Med; 1984 Aug; 144(8):1658-60. PubMed ID: 6235791 [No Abstract] [Full Text] [Related]
10. Cytotoxic drugs: their clinical application to the rheumatic diseases. Clements PJ; Davis J Semin Arthritis Rheum; 1986 May; 15(4):231-54. PubMed ID: 2872726 [No Abstract] [Full Text] [Related]
11. Methotrexate-induced mucositis with extra-mucosal involvement after acidental overdose. Rampon G; Henkin C; Jorge VM; Almeida HL An Bras Dermatol; 2018; 93(1):155-156. PubMed ID: 29641725 [No Abstract] [Full Text] [Related]
12. Oral effects of low-dose methotrexate treatment. Kalantzis A; Marshman Z; Falconer DT; Morgan PR; Odell EW Oral Surg Oral Med Oral Pathol Oral Radiol Endod; 2005 Jul; 100(1):52-62. PubMed ID: 15953917 [TBL] [Abstract][Full Text] [Related]
13. Acute bone marrow suppression following one day oral administration of methotrexate. Pierik MG R I Med J (1974); 1974 Aug; 57(8):332-3. PubMed ID: 4277987 [No Abstract] [Full Text] [Related]
15. Methotrexate in rheumatoid arthritis. Feedback on American College of Physicians guidelines. Tugwell P; Bennett K; Bell M; Gent M Ann Intern Med; 1989 Apr; 110(8):581-3. PubMed ID: 2648921 [No Abstract] [Full Text] [Related]
16. Methotrexate in rheumatoid arthritis: can current knowledge and experience justify its use as a first-line disease-modifying agent? Tariq S; Tariq SM Postgrad Med J; 1993 Oct; 69(816):775-80. PubMed ID: 8290407 [No Abstract] [Full Text] [Related]
17. Severe bone marrow suppression in a patient with rheumatoid arthritis on methotrexate. Iqbal MP; Ali AA; Alvi AA J Pak Med Assoc; 1993 Dec; 43(12):262-3. PubMed ID: 8133640 [No Abstract] [Full Text] [Related]
18. [Extra-articular manifestations of rheumatoid arthritis at the time of basic methotrexate treatment: apropos of a case of nodulosis with pericarditis]. Raccaud O Rev Med Suisse Romande; 1994 Apr; 114(4):343-4. PubMed ID: 8197353 [No Abstract] [Full Text] [Related]
19. Methotrexate-induced acute lung injury in a patient with rheumatoid arthritis. Taniguchi K; Usui Y; Matsuda T; Suzuki S; Fujiki K; Yakusiji F; Tomiyama J; Kinoshita K; Ilzuka H; Kuga Y Int J Clin Pharmacol Res; 2005; 25(3):101-5. PubMed ID: 16366417 [TBL] [Abstract][Full Text] [Related]
20. Longterm methotrexate therapy in rheumatoid arthritis: a review. Kremer JM J Rheumatol Suppl; 1985 Dec; 12 Suppl 12():25-8. PubMed ID: 3913773 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]